Cargando…
1512. Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population: A Retrospective Cohort Analysis
BACKGROUND: Staphylococcus aureus bacteremia (SAB) is a well-known cause of morbidity in pediatric patients; however, limited data are available regarding optimal antimicrobial therapy. The purpose of this study was to assess treatment outcomes associated with intravenous (IV) vs. oral (PO) stepdown...
Autores principales: | Gunter, Sarah G, Stover, Kayla R, Barber, Katie, Wagner, Jamie, Joyce Wingler, Mary, Cretella, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810567/ http://dx.doi.org/10.1093/ofid/ofz360.1376 |
Ejemplares similares
-
Intravenous versus Oral Step-Down for the Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population
por: Gunter, Sarah Grace, et al.
Publicado: (2022) -
597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
por: Wingler, Mary Joyce B, et al.
Publicado: (2018) -
Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series
por: Lowe, Rachel Amanda, et al.
Publicado: (2017) -
Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center
por: Markovich, Kylie, et al.
Publicado: (2022) -
Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia after Initial Clearance of Bloodstream Infection
por: Barber, Katie E., et al.
Publicado: (2021)